Ocular Manifestations Associated with Hematologic Malignancies: Mechanisms, Diagnosis, and Management. [PDF]
Xiao Y +5 more
europepmc +1 more source
Melatonin engages MT1/MT2 receptors to suppress STAT1‐driven USP18 upregulation, thereby redirecting PKM2 ubiquitination from K33‐linked autophagic degradation toward K27‐linked nuclear translocation. This prevents PKM2‐mediated proinflammatory gene expression in the heart, alleviating doxorubicin‐induced cardiotoxicity without compromising antitumor ...
Zhenyu Feng +10 more
wiley +1 more source
Antimicrobial Resistance Patterns in Infections Among Patients With Hematologic Malignancies: A Systematic Review. [PDF]
Kaur Soni T +13 more
europepmc +1 more source
A pH‐responsive ZIF‐8/2‐DG@Cu‐TA nanoplatform orchestrates multifaceted metabolic disruption for synergistic starvation‐immunotherapy. Acid‐triggered 2‐DG release blocks glycolysis, while Zn2+ overload induces mitochondrial dysfunction. Concurrently, Cx43‐mediated gap junctions redirect lipid droplets from tumor cells to cancer‐associated fibroblasts ...
Xianlong Zong +9 more
wiley +1 more source
Central Nervous System Toxoplasmosis Beyond HIV in Patients with Hematologic Malignancies: A Contemporary Narrative Review and Illustrative Case Synthesis. [PDF]
Łanocha A +5 more
europepmc +1 more source
MicroRNA‐941 Acts as a Novel Prognostic Predictor and Oncogenic Driver in Colorectal Cancer
Upregulation of miR‐941 was a promising diagnostic and prognostic biomarker for CRC patients. Inhibition of miR‐941 significantly suppressed CRC cellular events and triggered ferroptosis. The oncogenic functions of miR‐941 were mediated through targeting TRPS1.
Hong Li +5 more
wiley +1 more source
Leveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis. [PDF]
Brzechffa C, Fleischman AG.
europepmc +1 more source
The silent pharmacist: Harnessing the gut microbiome to improve therapy in hematologic malignancies. [PDF]
El-Sehrawy AAMA +1 more
europepmc +1 more source
Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies. [PDF]
Kemal CC +3 more
europepmc +1 more source
Heteroplasmic variants of mitochondrial genome in tumor and normal samples from patients with hematologic malignancies. [PDF]
Davini A +11 more
europepmc +1 more source

